Insider Transactions in Q3 2023 at Biomarin Pharmaceutical Inc (BMRN)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 16
2023
|
Jeffrey Robert Ajer EVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-7.6%
|
$450,000
$90.0 P/Share
|
|
Aug 10
2023
|
Henry J Fuchs President, Worldwide R&D |
SELL
Open market or private sale
|
Direct |
12,000
-6.38%
|
$1,080,000
$90.43 P/Share
|
|
Aug 09
2023
|
Charles Greg Guyer EVP, Chief Technical Officer |
SELL
Open market or private sale
|
Direct |
5,360
-11.81%
|
$498,480
$93.3 P/Share
|
|
Aug 08
2023
|
Jean Jacques Bienaime Director |
SELL
Open market or private sale
|
Direct |
6,000
-1.4%
|
$528,000
$88.29 P/Share
|
|
Aug 08
2023
|
George Eric Davis EVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
11,000
-13.67%
|
$979,000
$89.42 P/Share
|
|
Aug 07
2023
|
Jean Jacques Bienaime Director |
SELL
Open market or private sale
|
Direct |
4,000
-0.92%
|
$352,000
$88.1 P/Share
|